TrialBMC infectious diseases2026

Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic randomised controlled trial.

Yilin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.